Category Archives: IRT Webinar

Webinar on Successful IRT Partnerships

DDi-Webinar

Given the specialist nature of IRT systems, it is now almost impossible for mid and small-sized pharma companies, and biotechs, to develop or maintain bespoke, internally-managed IRT systems. Most company staffing protocols simply don’t allow for the kind of infrastructure necessary to maintain such a specialist team, so we must inevitably look elsewhere for specialist IRT service providers.

BUT..

What happens when individual study teams are given the responsibility to select and manage their own chosen IRT vendor? How often have we seen one team encountering seemingly insurmountable difficulties, leading any teams following in their footsteps to automatically reject that IRT vendor, select another and subsequently experience very similar problems? How much better could the experience be if we were to invest proper time and effort with a single selected vendor, over time learning from our mistakes, improving our procedures and passing on knowledge to the study teams following behind us?

  • What are the pitfalls when each team is allowed to select their own IRT vendor?
  • What does a good IRT vendor partnership look like?
  • What will we need to invest in order to develop a successful partnership?
  • How do we choose a partner?
  • Where could that partnership take us in the future?
Advertisements

Webinar : Reduce Build Time of IRT Systems.

DDi Webinar- IRT

As we move deeper into the 21st century, technologies available to clinical research teams are evolving at an ever-increasing rate. Whilst this evolution allows clinical trials to become increasingly smart and patient-centric it also runs the risk of making trials increasingly complicated with many more moving parts, third party vendors and data sources to integrate. With this in mind, how do we prevent these exciting new technologies that are designed to save us time and effort, from becoming the rate limiting steps in clinical trial set-up?

This webinar will examine both the stumbling blocks that have historically delayed the successful implementation of IRT systems and also new challenges that we increasingly face as the uptake in technological solutions intensifies. We will then explore some possible solutions; both quick-fixes and longer term strategies that will take IRT development off the table as a rate-limiting step in clinical trial set-up.

★ Understand the historical stumbling blocks that limit the speed of IRT set-up
★ Identify new challenges that emerge as technological solution uptake intensifies
★ Suggest some quick-fixes to see immediate improvements in development time
★ Explore potential longer-term strategies to reduce the build time of IRT

About Speaker:

Kate Chapman, the Director and Principal Consultant of Clinical Technology Consultants Ltd based in Winchester, UK, has 22 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, having worked at multiple Pharma companies including Novartis, Roche, Sanofi, BMS, Pharmacia and Shire, and has a deep expertise in IRT. Kate has extensive experience of IRT systems and continuously reviews many of the systems that are currently available and those that are under development. In her capacity as consultant, she works with both large Pharma and small Biotech companies helping them to get the most out their IRT systems and their partnerships with a wide variety of IRT vendors.

Webinar Replay on DEVELOPING IRT (#Clinical Supplies) & UAT: MAKING THE MOST OF YOUR #VENDOR PARTNERSHIPS

You can Watch our recording by register here: http://ddismart.com/webinar-registration-replay-on-developing-irt-uat-making-the-most-of-your-vendor-partnerships

Webinar_Linkedin.png

Webinar : Developing IRT & UAT Making The Most of Your Vendor Partnerships

banner_2160x1080px-3

The partner companies we work with are critical to our success and never more so than when we select and cooperate with an IRT service provider.  With a little careful thought and a positive internal approach our partnerships can be streamlined, efficient and rewarding for both sponsor and IRT vendor alike resulting in better IRT systems, built more speedily, at reduced cost and with a fraction of the customary frustration and duplication of effort.

In this session, you’ll learn:

  • Appreciating the importance of positive vendor partnerships
  • Developing a streamlined sponsor/vendor relationship
  • A modern approach to UAT
  • Best practices for UAT and beyond

About Our Speaker:

Kate Chapman, the Director of Clinical Technology Consultants Ltd. and the Principal Consultant, Clinical Technology Consultants, Winchester, UK, has 19 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, with a specialization in IRT. Kate has extensive experience as an end-user of IRT systems and continuously reviews many of the systems that are currently available. She worked with companies like Sandoz, Novartis, Innovex, Roche, Bristol Myers Squibb, Sanofi, Merck, Sharpe and Dohme, Pharmacia, PPD and Emergent Biosciences. Kate most recently formed and led an internal support function dedicated to IRT services and associated disciplines for Shire Pharmaceuticals.

Webinar on Best practices on INTERACTIVE RESPONSE TECHNOLOGY (IRT) and Clinical Supplies Management

blog-banner_640x320px-1

What exactly is an IRT system, why is it important in clinical trial, What does your Management demand and what do the IRT providers promise? These are the question the sponsors and clinical trial supply companies faces frequently. DDi is organizing this webinar focusing on the best  practices of the IRT systems and Clinical Supplies. IRT system delivers a wide range of applications for managing patient interactions and drug supplies throughout the trial life-cycle. The process includes Patient randomization, Product inventory management, Patient tracking,Study reporting, Drug accountability and reconciliation.But too often challenges arise among the team while  juggling many conflicting priorities. With a little careful preparation, and an efficient internal process, IRT development can be achieved in a streamlined fashion delivering an optimum IRT system with a fraction of the customary frustration and duplication of effort.

The points which the webinar will be highlighting are:

Appreciating the importance of IRT
Understanding your own organization
An analysis of previous approaches and the implications thereof
Discussion of best practices

Speaker:
Kate Chapman
Former Associate Director, IRT Services,
Shire Pharmaceuticals
Director & Principal Consultant,
Clinical Technology Consultants Ltd.

Moderator:
Priya Kurian
Product Specialist, DDi

About Speaker:

Kate Chapman, the Director of Clinical Technology Consultants Ltd and the Principal Consultant. Clinical Technology Consultants from Winchester,UK, has 19 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, with a specialization in IRT. Kate has extensive experience as an end-user of IRT systems and continuously reviews many of the systems that are currently available. She worked with companies like Sandoz, Novartis, Innovex, Roche, Bristol Myers Squibb, Sanofi, Merck, Sharpe and Dohme, Pharmacia, PPD and Emergent Biosciences. Kate most recently formed and led an internal support function dedicated to IRT services and associated disciplines for Shire Pharmaceuticals.